局部-话题@MedSci

#局部#

598篇内容 | 2712人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1406173, encodeId=287014061e3bb, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=度伐利尤单抗治疗局部晚期宫颈癌III期研究，结果失败, objectType=article, longId=302279, objectId=6eee3022e979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6eee3022e979, replyNumber=0, likeNumber=107, createdTime=2022-04-04, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6eee3022e979, moduleTitle=度伐利尤单抗治疗局部晚期宫颈癌III期研究，结果失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6eee3022e979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406172, encodeId=8e6114061e2c1, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性, objectType=article, longId=301810, objectId=b131301810c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b131301810c5, replyNumber=0, likeNumber=76, createdTime=2022-03-29, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b131301810c5, moduleTitle=J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b131301810c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406170, encodeId=ac3e14061e07c, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=ESMO：化疗联合纳武利尤单抗对局部晚期可切除NSCLC治疗，42个月OS率达87.3%（NADIM研究）, objectType=article, longId=301725, objectId=d251301e254c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d251301e254c, replyNumber=0, likeNumber=90, createdTime=2022-03-28, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d251301e254c, moduleTitle=ESMO：化疗联合纳武利尤单抗对局部晚期可切除NSCLC治疗，42个月OS率达87.3%（NADIM研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d251301e254c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406171, encodeId=56b014061e1bd, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=局部血管扩张剂诱导的药理学延迟对皮瓣活力和血管重塑的影响, objectType=article, longId=301532, objectId=46ab3015329d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46ab3015329d, replyNumber=0, likeNumber=81, createdTime=2022-03-25, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46ab3015329d, moduleTitle=局部血管扩张剂诱导的药理学延迟对皮瓣活力和血管重塑的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46ab3015329d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406169, encodeId=81f11406169a8, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Clin Oncol：国内多中心III期研究表明局部进展期直肠癌术前短程放疗+化疗（TNT）是可行的治疗方案, objectType=article, longId=300860, objectId=e92c300860d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e92c300860d9, replyNumber=0, likeNumber=141, createdTime=2022-03-17, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e92c300860d9, moduleTitle=J Clin Oncol：国内多中心III期研究表明局部进展期直肠癌术前短程放疗+化疗（TNT）是可行的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e92c300860d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406168, encodeId=1e821406168cd, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Oncologist：局部进展期直肠癌(LARC)患者使用完全新辅助治疗(TNT)模式治疗并未能改善预后, objectType=article, longId=300702, objectId=67e2300e0251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e2300e0251, replyNumber=0, likeNumber=86, createdTime=2022-03-15, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e2300e0251, moduleTitle=Oncologist：局部进展期直肠癌(LARC)患者使用完全新辅助治疗(TNT)模式治疗并未能改善预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67e2300e0251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406167, encodeId=e4fd140616e95, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Clin Oncol：中科院&协和 | 术前短程放疗+化疗方案或可替代局部晚期直肠癌的标准长程放化疗方案！, objectType=article, longId=300486, objectId=097730048604, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=097730048604, replyNumber=0, likeNumber=70, createdTime=2022-03-12, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=097730048604, moduleTitle=J Clin Oncol：中科院&协和 | 术前短程放疗+化疗方案或可替代局部晚期直肠癌的标准长程放化疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=097730048604)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406165, encodeId=fd01140616571, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效, objectType=article, longId=300287, objectId=836930028e24, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=836930028e24, replyNumber=0, likeNumber=96, createdTime=2022-03-10, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=836930028e24, moduleTitle=Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=836930028e24)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406166, encodeId=201b140616602, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Clin Oncol：JCOG1008研究表明高复发风险局部晚期头颈癌术后顺铂每周+放疗不劣效于顺铂三周方案, objectType=article, longId=300283, objectId=9daa30028368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9daa30028368, replyNumber=0, likeNumber=81, createdTime=2022-03-10, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9daa30028368, moduleTitle=J Clin Oncol：JCOG1008研究表明高复发风险局部晚期头颈癌术后顺铂每周+放疗不劣效于顺铂三周方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9daa30028368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406164, encodeId=4d411406164ee, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Cell封面：国内学者发现米色脂肪局部热疗就可能减肥, objectType=article, longId=300233, objectId=6a0e300233be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a0e300233be, replyNumber=0, likeNumber=85, createdTime=2022-03-09, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a0e300233be, moduleTitle=Cell封面：国内学者发现米色脂肪局部热疗就可能减肥, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a0e300233be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406163, encodeId=c5de140616304, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Eur Urol：恩福单抗维多汀治疗局部晚期或转移性尿路上皮癌的疗效如何？, objectType=article, longId=299913, objectId=686d29991338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=686d29991338, replyNumber=0, likeNumber=54, createdTime=2022-03-03, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=686d29991338, moduleTitle=Eur Urol：恩福单抗维多汀治疗局部晚期或转移性尿路上皮癌的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=686d29991338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406162, encodeId=985d14061628c, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=BMC Cancer：多中心倾向匹配分析比较术前 vs 术后放化疗治疗局部进展胃癌患者的疗效, objectType=article, longId=299728, objectId=d846299e2851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d846299e2851, replyNumber=0, likeNumber=124, createdTime=2022-03-01, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d846299e2851, moduleTitle=BMC Cancer：多中心倾向匹配分析比较术前 vs 术后放化疗治疗局部进展胃癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d846299e2851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406161, encodeId=ba3a140616130, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效, objectType=article, longId=299451, objectId=fc31299451e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc31299451e9, replyNumber=0, likeNumber=31, createdTime=2022-02-24, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc31299451e9, moduleTitle=Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc31299451e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406160, encodeId=04df1406160aa, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果 , objectType=article, longId=299087, objectId=d12e29908ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d12e29908ecd, replyNumber=0, likeNumber=107, createdTime=2022-02-19, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d12e29908ecd, moduleTitle=Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d12e29908ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406159, encodeId=cc7a1406159da, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Front.aging-neurosci-正常老化大脑中局部脑葡萄糖代谢的性别相关差异, objectType=article, longId=299038, objectId=31c329903849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31c329903849, replyNumber=0, likeNumber=101, createdTime=2022-02-19, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31c329903849, moduleTitle=Front.aging-neurosci-正常老化大脑中局部脑葡萄糖代谢的性别相关差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31c329903849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406158, encodeId=42bf140615838, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=皮肤伤口基质的效用与局部组织重排和游离皮瓣重建对肿瘤性头皮伤口的比较, objectType=article, longId=295721, objectId=5204295e2142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5204295e2142, replyNumber=0, likeNumber=83, createdTime=2022-02-17, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5204295e2142, moduleTitle=皮肤伤口基质的效用与局部组织重排和游离皮瓣重建对肿瘤性头皮伤口的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5204295e2142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406157, encodeId=7db3140615e32, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Front Oncol：探索不可切除肺腺癌患者局部放疗的更佳介入时间点, objectType=article, longId=295661, objectId=5a7e29566140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a7e29566140, replyNumber=0, likeNumber=63, createdTime=2022-02-16, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a7e29566140, moduleTitle=Front Oncol：探索不可切除肺腺癌患者局部放疗的更佳介入时间点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a7e29566140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406156, encodeId=dd9a14061560d, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Clin Cancer Res：局部晚期直肠癌的新治疗方案——术前放化疗联合纳武单抗巩固继以根治性手术！, objectType=article, longId=295321, objectId=eb062953218f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb062953218f, replyNumber=0, likeNumber=94, createdTime=2022-02-10, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb062953218f, moduleTitle=Clin Cancer Res：局部晚期直肠癌的新治疗方案——术前放化疗联合纳武单抗巩固继以根治性手术！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb062953218f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406155, encodeId=4cda140615555, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Thorac Cancer：局部晚期可切除食管鳞状细胞癌(ESCC)使用脂质体紫杉醇+铂类方案作为新辅助化疗的疗效和安全性, objectType=article, longId=295185, objectId=293529518574, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=293529518574, replyNumber=0, likeNumber=93, createdTime=2022-02-07, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=293529518574, moduleTitle=Thorac Cancer：局部晚期可切除食管鳞状细胞癌(ESCC)使用脂质体紫杉醇+铂类方案作为新辅助化疗的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=293529518574)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1406154, encodeId=eaa11406154b1, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Front Oncol：一线TKI联合局部放疗可改善老年NSCLC伴有寡转移患者预后, objectType=article, longId=295051, objectId=4a0729505129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a0729505129, replyNumber=0, likeNumber=78, createdTime=2022-02-04, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a0729505129, moduleTitle=Front Oncol：一线TKI联合局部放疗可改善老年NSCLC伴有寡转移患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a0729505129)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

局部

2020-05-29

chg122 (审核中...)

前往app查看评论内容

#局部#

度伐利尤单抗治疗局部晚期宫颈癌III期研究，结果失败

2022-04-04

chg122 (审核中...)

前往app查看评论内容

#局部#

J Immunother Cancer：卡瑞利珠单抗+化疗作为局部晚期食管癌术前辅助治疗的疗效和安全性

2022-03-29

chg122 (审核中...)

前往app查看评论内容

#局部#

ESMO：化疗联合纳武利尤单抗对局部晚期可切除NSCLC治疗，42个月OS率达87.3%（NADIM研究）

2022-03-28

chg122 (审核中...)

前往app查看评论内容

#局部#

局部血管扩张剂诱导的药理学延迟对皮瓣活力和血管重塑的影响

2022-03-25

chg122 (审核中...)

前往app查看评论内容

#局部#

J Clin Oncol：国内多中心III期研究表明局部进展期直肠癌术前短程放疗+化疗（TNT）是可行的治疗方案

2022-03-17

chg122 (审核中...)

前往app查看评论内容

#局部#

Oncologist：局部进展期直肠癌(LARC)患者使用完全新辅助治疗(TNT)模式治疗并未能改善预后

2022-03-15

chg122 (审核中...)

前往app查看评论内容

#局部#

J Clin Oncol：中科院&协和 | 术前短程放疗+化疗方案或可替代局部晚期直肠癌的标准长程放化疗方案！

2022-03-12

chg122 (审核中...)

前往app查看评论内容

#局部#

Clin Cancer Res：帕博利珠单抗新辅助和辅助治疗可切除局部晚期头颈部鳞状细胞癌患者的疗效

2022-03-10

chg122 (审核中...)

前往app查看评论内容

#局部#

J Clin Oncol：JCOG1008研究表明高复发风险局部晚期头颈癌术后顺铂每周+放疗不劣效于顺铂三周方案

2022-03-10

chg122 (审核中...)

前往app查看评论内容

#局部#

Cell封面：国内学者发现米色脂肪局部热疗就可能减肥

2022-03-09

chg122 (审核中...)

前往app查看评论内容

#局部#

Eur Urol：恩福单抗维多汀治疗局部晚期或转移性尿路上皮癌的疗效如何？

2022-03-03

chg122 (审核中...)

前往app查看评论内容

#局部#

BMC Cancer：多中心倾向匹配分析比较术前 vs 术后放化疗治疗局部进展胃癌患者的疗效

2022-03-01

chg122 (审核中...)

前往app查看评论内容

#局部#

Oncologist：Toripalimab（特瑞普利单抗）联合紫杉醇+卡铂新辅助治疗可切除局部晚期食管鳞状细胞癌的疗效

2022-02-24

chg122 (审核中...)

前往app查看评论内容

#局部#

Eur Urol：非转移性前列腺癌患者中，高强度聚焦超声局部治疗后的癌症控制结果

2022-02-19

chg122 (审核中...)

前往app查看评论内容

#局部#

Front.aging-neurosci-正常老化大脑中局部脑葡萄糖代谢的性别相关差异

2022-02-19

chg122 (审核中...)

前往app查看评论内容

#局部#

皮肤伤口基质的效用与局部组织重排和游离皮瓣重建对肿瘤性头皮伤口的比较

2022-02-17

chg122 (审核中...)

前往app查看评论内容

#局部#

Front Oncol：探索不可切除肺腺癌患者局部放疗的更佳介入时间点

2022-02-16

chg122 (审核中...)

前往app查看评论内容

#局部#

Clin Cancer Res：局部晚期直肠癌的新治疗方案——术前放化疗联合纳武单抗巩固继以根治性手术！

2022-02-10

chg122 (审核中...)

前往app查看评论内容

#局部#

Thorac Cancer：局部晚期可切除食管鳞状细胞癌(ESCC)使用脂质体紫杉醇+铂类方案作为新辅助化疗的疗效和安全性

2022-02-07

chg122 (审核中...)

前往app查看评论内容

#局部#

Front Oncol：一线TKI联合局部放疗可改善老年NSCLC伴有寡转移患者预后

2022-02-04

科室
- - 订阅+
  - 更多科室
工具
服务